{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:01:15Z","timestamp":1790841675878,"version":"4.1.0"},"reference-count":128,"publisher":"Bentham Science Publishers Ltd.","issue":"46","funder":[{"DOI":"10.13039\/501100001409","name":"DST EMR, New Delhi, India","doi-asserted-by":"publisher","award":["EMR\/2016\/002694"],"award-info":[{"award-number":["EMR\/2016\/002694"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"name":"RSG, GITAM","award":["2021\/0044"],"award-info":[{"award-number":["2021\/0044"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in Wuhan,\nthe Hubei region of China, has become a pandemic worldwide. It can transmit through droplets and enter via\noral, nasal, and eye mucous membranes. It consists of single-stranded RNA (positive-sense), nonstructural proteins\nincluding enzymes and transcriptional proteins, and structural proteins such as Spike, Membrane, Envelope,\nand Nucleocapsid -proteins. SARS-CoV-2 mediates S-proteins entry and exit via binding to host cell surface\nproteins like tetraspanins. The transmembrane tetraspanins, CD151, CD9, and tetraspanin 8 (TSPAN8),\nfacilitate the entry of novel coronaviruses by scaffolding host cell receptors and proteases. Also, CD151 was\nreported to increase airway hyperresponsiveness to calcium and nuclear viral export signaling. They may facilitate\nentry and exit by activating the serine proteases required to prime S-proteins in tetraspanin-enriched microdomains\n(TEMs). This article updates recent advances in structural proteins, their epitopes and putative receptors,\nand their regulation by proteases associated with TEMs. This review furnishes recent updates on the role\nof CD151 in the pathophysiology of SARS-CoV-2. We describe the role of CD151 in a possible mechanism of\nentry and exit in the airway, a major site for infection of SARS-CoV-2. We also updated current knowledge on\nthe role of CD9 and TSPAN 8 in the entry and exit mechanism of coronaviruses. Finally, we discussed the importance\nof some small molecules which target CD151 as possible targeted therapeutics for COVID-19. In conclusion,\nthis study could identify new targets and specific therapeutics to control emerging virus infections.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612828666220907105543","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T11:19:20Z","timestamp":1662722360000},"page":"3649-3657","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tetraspanin-enriched Microdomain Containing CD151, CD9, and TSPAN 8 \u2013\nPotential Mediators of Entry and Exit Mechanisms in Respiratory Viruses Including\nSARS-CoV-2"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2448-1681","authenticated-orcid":true,"given":"RamaRao","family":"Malla","sequence":"first","affiliation":[{"name":"Cancer Biology Lab, Department of Biochemistry and Bioinformatics, School of Science, GITAM (Deemed to be University),\nVisakhapatnam-530045, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-0565","authenticated-orcid":true,"given":"Mohammad Amjad","family":"Kamal","sequence":"additional","affiliation":[{"name":"Institutes for Systems Genetics, Frontiers Science Center for Disease-related\nMolecular Network, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China"},{"name":"King Fahd Medical Research\nCenter, King Abdulaziz University, Jeddah, Saudi Arabia"},{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil\nInternational University, Ashulia, Bangladesh"},{"name":"Enzymoics, Novel Global Community Educational Foundation, 7 Peterlee Place,\nHebersham NSW 2770, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1016\/j.ijtb.2020.09.031","volume":"67","author":"Matta S.","year":"2020","unstructured":"Matta S.; Chopra K.K.; Arora V.K.; Morbidity and mortality trends of COVID 19 in top 10 countries. Indian J Tuberc 2020,67(4),S167-S172","journal-title":"Indian J Tuberc"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","volume":"399","author":"Wang H.","year":"2022","unstructured":"Wang H.; Paulson K.R.; Pease S.A.; Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020\u201321. Lancet 2022,399(10334),1513-1536","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/anae.15532","volume":"76","author":"Taylor E.H.","year":"2021","unstructured":"Taylor E.H.; Marson E.J.; Elhadi M.; Factors associated with mortality in patients with COVID\u201019 admitted to intensive care: A systematic review and meta\u2010analysis. Anaesthesia 2021,76(9),1224-1232","journal-title":"Anaesthesia"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"102212","DOI":"10.1016\/j.dsx.2021.102212","volume":"15","author":"Jain V.K.","year":"2021","unstructured":"Jain V.K.; Iyengar K.P.; Ish P.; Elucidating causes of COVID-19 infection and related deaths after vaccination. Diabetes Metab Syndr 2021,15(5),102212","journal-title":"Diabetes Metab Syndr"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40779-020-00240-0","volume":"7","author":"Guo Y.R.","year":"2020","unstructured":"Guo Y.R.; Cao Q.D.; Hong Z.S.; The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 an update on the status. Mil Med Res 2020,7(1),11","journal-title":"Mil Med Res"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41368-020-0075-9","volume":"12","author":"Peng X.","year":"2020","unstructured":"Peng X.; Xu X.; Li Y.; Cheng L.; Zhou X.; Ren B.; Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci 2020,12,9","journal-title":"Int J Oral Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","volume":"12","author":"Xu H.","year":"2020","unstructured":"Xu H.; Zhong L.; Deng J.; High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020,12(1),8","journal-title":"Int J Oral Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"Huang C.","year":"2020","unstructured":"Huang C.; Wang Y.; Li X.; Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020,395(10223),497-506","journal-title":"Lancet"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"Zou X.","year":"2020","unstructured":"Zou X.; Chen K.; Zou J.; Han P.; Hao J.; Han Z.; Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 2020,14(2),185-192","journal-title":"Front Med"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","volume":"11","author":"Baig A.M.","year":"2020","unstructured":"Baig A.M.; Khaleeq A.; Ali U.; Syeda H.; Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020,11(7),995-998","journal-title":"ACS Chem Neurosci"},{"key":"ref=11","first-page":"235","volume":"54","author":"Tian H.Y.","year":"2020","unstructured":"Tian H.Y.; 2019-nCoV: New challenges from coronavirus. Chin J Prev Med 2020,54(3),235-238","journal-title":"Chin J Prev Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"Cui J.","year":"2019","unstructured":"Cui J.; Li F.; Shi Z.L.; Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019,17,181-192","journal-title":"Nat Rev Microbiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"taaa041","DOI":"10.1093\/jtm\/taaa041","volume":"27","author":"Diaz J.H.","year":"2020","unstructured":"Diaz J.H.; Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J Travel Med 2020,27(3),taaa041","journal-title":"J Travel Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jmv.25726","volume":"92","author":"Liu Z.","year":"2020","unstructured":"Liu Z.; Xiao X.; Wei X.; Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol 2020,92(6),595-601","journal-title":"J Med Virol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1111\/febs.15303","volume":"287","author":"Olds J.L.","year":"2020","unstructured":"Olds J.L.; Kabbani N.; Is nicotine exposure linked to cardiopulmonary vulnerability to COVID\u201019 in the general population? FEBS J 2020,287(17),3651-3655","journal-title":"FEBS J"},{"key":"ref=16","first-page":"411","volume":"49","author":"Yao X.H.","year":"2020","unstructured":"Yao X.H.; Li T.Y.; He Z.C.; A pathological report of three COVID-19 cases by minimally invasive autopsies. Chinese J Pathol 2020,49,411-417","journal-title":"Chinese J Pathol"},{"key":"ref=17","first-page":"471","volume":"49","author":"Kuang D.","year":"2020","unstructured":"Kuang D.; Xu S.P.; Hu Y.; Liu C.; Duan Y.Q.; Wang G.P.; The pathological changes and related studies of novel coronavirus infected surgical specimen. Chinese J Pathol 2020,49,471-473","journal-title":"Chinese J Pathol"},{"key":"ref=18","first-page":"e00169","volume":"9","author":"Sah R.","year":"2020","unstructured":"Sah R.; Rodriguez-Morales A.J.; Complete genome sequence of a 2019 novel coronavirus (SARS-CoV-2) strain isolated in Nepal. Microbiol Resour Announc 2020,9(11),e00169","journal-title":"Microbiol Resour Announc"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"104212","DOI":"10.1016\/j.meegid.2020.104212","volume":"79","author":"Paraskevis D.","year":"2020","unstructured":"Paraskevis D.; Kostaki E.G.; Magiorkinis G.; Panayiotakopoulos G.; Sourvinos G.; Tsiodras S.; Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 2020,79,104212","journal-title":"Infect Genet Evol"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Liu Q.; Guo D.; Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020,92,418-423","journal-title":"J Med Virol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"Wrapp D.","year":"2020","unstructured":"Wrapp D.; Wang N.; Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020,367,1260-1263","journal-title":"Science"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1042\/CS20200163","volume":"134","author":"Batlle D.","year":"2020","unstructured":"Batlle D.; Wysocki J.; Satchell K.; Soluble angiotensin-converting enzyme 2: A potential approach for coronavirus infection therapy? Clin Sci 2020,134(5),543-545","journal-title":"Clin Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.cell.2020.11.032","volume":"183","author":"Walls A.C.","year":"2020","unstructured":"Walls A.C.; Park Y.J.; Tortorici M.A.; Wall A.; McGuire A.T.; Veesler D.; Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 2020,183(6),1735","journal-title":"Cell"},{"key":"ref=24","first-page":"2006","volume":"24","author":"Kannan S.","year":"2020","unstructured":"Kannan S.; Shaik Syed Ali P.; Sheeza A.; Hemalatha K.; COVID-19 (Novel Coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci 2020,24(4),2006-2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-4614-0980-9_10","volume":"726","author":"Wilen C.B.","year":"2012","unstructured":"Wilen C.B.; Tilton J.C.; Doms R.W.; Molecular mechanisms of HIV entry. Adv Exp Med Biol 2012,726,223-242","journal-title":"Adv Exp Med Biol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1128\/CMR.00045-12","volume":"25","author":"Colpitts T.M.","year":"2012","unstructured":"Colpitts T.M.; Conway M.J.; Montgomery R.R.; Fikrig E.; West Nile Virus: Biology, transmission, and human infection. Clin Microbiol Rev 2012,25(4),635-648","journal-title":"Clin Microbiol Rev"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e1008656","DOI":"10.1371\/journal.ppat.1008656","volume":"16","author":"Sieben C.","year":"2020","unstructured":"Sieben C.; Sezgin E.; Eggeling C.; Manley S.; Influenza A viruses use multivalent sialic acid clusters for cell binding and receptor activation. PLoS Pathog 2020,16(7),e1008656","journal-title":"PLoS Pathog"},{"key":"ref=28","first-page":"E015","volume":"43","year":"2020","unstructured":"Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control. Chinese J Tuberculosis Resp Dis 2020,43,E015","journal-title":"Chinese J Tuberculosis Resp Dis"},{"key":"ref=29","first-page":"E014","volume":"43","author":"Sun M.L.","year":"2020","unstructured":"Sun M.L.; Yang J.M.; Sun Y.P.; Su G.H.; Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. Chinese J Tuberculosis Resp Dis 2020,43(0),E014","journal-title":"Chinese J Tuberculosis Resp Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"Li W.","year":"2003","unstructured":"Li W.; Moore M.J.; Vasilieva N.; Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003,426(6965),450-454","journal-title":"Nature"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"Kuba K.","year":"2005","unstructured":"Kuba K.; Imai Y.; Rao S.; A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat Med 2005,11(8),875-879","journal-title":"Nat Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","volume":"6","author":"Cao Y.","year":"2020","unstructured":"Cao Y.; Li L.; Feng Z.; Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov 2020,6(1),11","journal-title":"Cell Discov"},{"key":"ref=33","first-page":"E016","volume":"43","author":"Liu M.","year":"2020","unstructured":"Liu M.; He P.; Liu H.G.; Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia. Chinese J Tuberculosis Resp Dis 2020,43(0),E016","journal-title":"Chinese J Tuberculosis Resp Dis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"Jackson C.B.","year":"2022","unstructured":"Jackson C.B.; Farzan M.; Chen B.; Choe H.; Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 2022,23(1),3-20","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","volume":"525","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Guo Y.; Pan Y.; Zhao Z.J.; Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun 2020,525(1),135-140","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jmv.25698","volume":"92","author":"Baruah V.","year":"2020","unstructured":"Baruah V.; Bose S.; Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV. J Med Virol 2020,92,495-500","journal-title":"J Med Virol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/cid\/ciaa310","volume":"71","author":"Guo L.","year":"2020","unstructured":"Guo L.; Ren L.; Yang S.; Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis 2020,71(15),778-785","journal-title":"Clin Infect Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"ofaa102","DOI":"10.1093\/ofid\/ofaa102","volume":"7","author":"Cao W.","year":"2020","unstructured":"Cao W.; Liu X.; Bai T.; High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus disease 2019. Open Forum Infect Dis 2020,7(3),ofaa102","journal-title":"Open Forum Infect Dis"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/cid\/ciaa322","volume":"71","author":"Sun Y.","year":"2020","unstructured":"Sun Y.; Koh V.; Marimuthu K.; Epidemiological and clinical predictors of COVID-19. Clin Infect Dis 2020,71(15),786-792","journal-title":"Clin Infect Dis"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"de Wit E.","year":"2016","unstructured":"de Wit E.; van Doremalen N.; Falzarano D.; Munster V.J.; SARS and MERS: Recent insights into emerging coronaviruses. Nat Rev Microbiol 2016,14(8),523-534","journal-title":"Nat Rev Microbiol"},{"key":"ref=41","first-page":"145","volume":"41","author":"Novel C.P.E.R.E.","year":"2020","unstructured":"Novel C.P.E.R.E.; The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese J Epidemiol 2020,41,145-151","journal-title":"Chinese J Epidemiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1371\/journal.ppat.0030005","volume":"3","author":"Roberts A.","year":"2007","unstructured":"Roberts A.; Deming D.; Paddock C.D.; A mouse-adapted SARS-coronavirus causes disease and mortality in BALB\/c mice. PLoS Pathog 2007,3(1),e5","journal-title":"PLoS Pathog"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"Wang M.","year":"2020","unstructured":"Wang M.; Cao R.; Zhang L.; Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020,30(3),269-271","journal-title":"Cell Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"104541","DOI":"10.1016\/j.antiviral.2019.104541","volume":"169","author":"Brown A.J.","year":"2019","unstructured":"Brown A.J.; Won J.J.; Graham R.L.; Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral Res 2019,169,104541","journal-title":"Antiviral Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","volume":"14","author":"Gao J.","year":"2020","unstructured":"Gao J.; Tian Z.; Yang X.; Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020,14(1),72-73","journal-title":"Biosci Trends"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"e00203","DOI":"10.1128\/mSphere.00203-20","volume":"5","author":"Weston S.","year":"2020","unstructured":"Weston S.; Frieman M.B.; COVID-19: Knowns, unknowns, and questions. MSphere 2020,5(2),e00203-e00220","journal-title":"MSphere"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"Hoffmann M.","year":"2020","unstructured":"Hoffmann M.; Kleine-Weber H.; Schroeder S.; SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020,181(2),271-280.e8","journal-title":"Cell"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.2147\/IDR.S308176","volume":"14","author":"Dessie G.","year":"2021","unstructured":"Dessie G.; Malik T.; Role of serine proteases and host cell receptors involved in proteolytic activation, entry of SARS-CoV-2 and its current therapeutic options. Infect Drug Resist 2021,14,1883-1892","journal-title":"Infect Drug Resist"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e00970","DOI":"10.1128\/mBio.00970-21","volume":"12","author":"Li K.","year":"2021","unstructured":"Li K.; Meyerholz D.K.; Bartlett J.A.; McCray P.B.; The TMPRSS2 inhibitor nafamostat reduces SARS-CoV-2 pulmonary infection in mouse models of COVID-19. MBio 2021,12(4),e00970-e21","journal-title":"MBio"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"23177","DOI":"10.1074\/jbc.R109.021006","volume":"284","author":"Bugge T.H.","year":"2009","unstructured":"Bugge T.H.; Antalis T.M.; Wu Q.; Type II transmembrane serine proteases. J Biol Chem 2009,284(35),23177-23181","journal-title":"J Biol Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"Matsuyama S.","year":"2020","unstructured":"Matsuyama S.; Nao N.; Shirato K.; Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci USA 2020,117(13),7001-7003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-022-04661-w","volume":"605","author":"Shapira T.","year":"2022","unstructured":"Shapira T.; Monreal I.A.; Dion S.P.; A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. Nature 2022,605(7909),340-348","journal-title":"Nature"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e107821","DOI":"10.15252\/embj.2021107821","volume":"40","author":"Koch J.","year":"2021","unstructured":"Koch J.; Uckeley Z.M.; Doldan P.; Stanifer M.; Boulant S.; Lozach P.Y.; TMPRSS2 expression dictates the entry route used by SARS\u2010CoV\u20102 to infect host cells. EMBO J 2021,40(16),e107821","journal-title":"EMBO J"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.1002\/jmv.27244","volume":"93","author":"Zhang F.","year":"2021","unstructured":"Zhang F.; Li W.; Feng J.; SARS\u2010CoV\u20102 pseudovirus infectivity and expression of viral entry\u2010related factors ACE2, TMPRSS2, Kim\u20101, and NRP\u20101 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems. J Med Virol 2021,93(12),6671-6685","journal-title":"J Med Virol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"21415","DOI":"10.1038\/s41598-020-78402-2","volume":"10","author":"Wruck W.","year":"2020","unstructured":"Wruck W.; Adjaye J.; SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress. Sci Rep 2020,10(1),21415","journal-title":"Sci Rep"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","volume":"11","author":"Zhao H.","year":"2022","unstructured":"Zhao H.; Lu L.; Peng Z.; SARS-CoV-2 omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg Microbes Infect 2022,11(1),277-283","journal-title":"Emerg Microbes Infect"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"Meng B.","year":"2022","unstructured":"Meng B.; Abdullahi A.; Ferreira I.A.T.M.; Altered TMPRSS2 usage by SARS-CoV-2 omicron impacts infectivity and fusogenicity. Nature 2022,603(7902),706-714","journal-title":"Nature"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"e1008461","DOI":"10.1371\/journal.pcbi.1008461","volume":"16","author":"Padmanabhan P.","year":"2020","unstructured":"Padmanabhan P.; Desikan R.; Dixit N.M.; Targeting TMPRSS2 and Cathepsin B\/L together may be synergistic against SARS-CoV-2 infection. PLOS Comput Biol 2020,16(12),e1008461","journal-title":"PLOS Comput Biol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","volume":"11","author":"Ou X.","year":"2020","unstructured":"Ou X.; Liu Y.; Lei X.; Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 2020,11(1),1620","journal-title":"Nat Commun"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.antiviral.2013.09.028","volume":"100","author":"Simmons G.","year":"2013","unstructured":"Simmons G.; Zmora P.; Gierer S.; Heurich A.; P&#xF6;hlmann S.; Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research. Antiviral Res 2013,100(3),605-614","journal-title":"Antiviral Res"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"101212","DOI":"10.1016\/j.isci.2020.101212","volume":"23","author":"Jaimes J.","year":"2020","unstructured":"Jaimes J.; Millet J.; Whittaker G.; Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1\/S2 site. iScience 2020,23(6),101212","journal-title":"iScience"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1128\/JVI.00543-15","volume":"89","author":"Earnest J.T.","year":"2015","unstructured":"Earnest J.T.; Hantak M.P.; Park J.E.; Gallagher T.; Coronavirus and influenza virus proteolytic priming takes place in tetraspanin-enriched membrane microdomains. J Virol 2015,89(11),6093-6104","journal-title":"J Virol"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"Vankadari N.","year":"2020","unstructured":"Vankadari N.; Wilce J.A.; Emerging Wuhan (COVID-19) coronavirus: Glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect 2020,9,601-604","journal-title":"Emerg Microbes Infect"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"BIC.S21847","DOI":"10.4137\/BIC.S21847","volume":"7","author":"Kumari S","year":"2015","unstructured":"Kumari S; Gayatri Devi V; Badana A; Dasari VR; Malla RR; CD151\u2014A striking marker for cancer therapy. Biomark Cancer 2015,7,BIC.S21847","journal-title":"Biomark Cancer"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.1073\/pnas.78.10.6246","volume":"78","author":"Sowers A.E.","year":"1981","unstructured":"Sowers A.E.; Hackenbrock C.R.; Rate of lateral diffusion of intramembrane particles: Measurement by electrophoretic displacement and rerandomization. Proc Natl Acad Sci USA 1981,78(10),6246-6250","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/PL00000933","volume":"58","author":"Boucheix C.","year":"2001","unstructured":"Boucheix C.; Rubinstein E.; Tetraspanins. Cell Mol Life Sci 2001,58(9),1189-1205","journal-title":"Cell Mol Life Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1042\/bj20031037","volume":"377","author":"Kovalenko O.V.","year":"2004","unstructured":"Kovalenko O.V.; Yang X.; Kolesnikova T.V.; Hemler M.E.; Evidence for specific tetraspanin homodimers: Inhibition of palmitoylation makes cysteine residues available for cross-linking. Biochem J 2004,377(2),407-417","journal-title":"Biochem J"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200508165","volume":"173","author":"Nydegger S.","year":"2006","unstructured":"Nydegger S.; Khurana S.; Krementsov D.N.; Foti M.; Thali M.; Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1. J Cell Biol 2006,173(5),795-807","journal-title":"J Cell Biol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"6455","DOI":"10.3390\/molecules26216455","volume":"26","author":"Nassar A.","year":"2021","unstructured":"Nassar A.; Ibrahim I.M.; Amin F.G.; A review of human coronaviruses\u2019 receptors: The host-cell targets for the crown bearing viruses. Molecules 2021,26(21),6455","journal-title":"Molecules"},{"key":"ref=70","author":"Zhu Y.","year":"2019","unstructured":"Zhu Y.; Saint-Pol J.; Nguyen V.; Rubinstein E.; Greco C.; Boucheix C.; The Tetraspanin Tspan8\/Co-029 associates with Endothelin converting enzyme ECE1 and regulates its activity. Thesis, L\u2019universite Paris-Saclay, France 2019","journal-title":"Thesis, L\u2019universite Paris-Saclay, France"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"P43","DOI":"10.1186\/cc5830","volume":"11","author":"Makdisse M.R.P.","year":"2007","unstructured":"Makdisse M.R.P.; Correa A.G.; Knobel M.; Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction. Crit Care 2007,11(Suppl. 3),P43","journal-title":"Crit Care"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.fertnstert.2012.04.029","volume":"98","author":"Inoue N.","year":"2012","unstructured":"Inoue N.; Nishikawa T.; Ikawa M.; Okabe M.; Tetraspanin-interacting protein IGSF8 is dispensable for mouse fertility. Fertil Steril 2012,98(2),465-470","journal-title":"Fertil Steril"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3389\/fimmu.2018.01140","volume":"9","author":"Florin L.","year":"2018","unstructured":"Florin L.; Lang T.; Tetraspanin assemblies in virus infection. Front Immunol 2018,9,1140","journal-title":"Front Immunol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.micinf.2009.11.001","volume":"12","author":"van Spriel A.B.","year":"2010","unstructured":"van Spriel A.B.; Figdor C.G.; The role of tetraspanins in the pathogenesis of infectious diseases. Microbes Infect 2010,12(2),106-112","journal-title":"Microbes Infect"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/187152612798994957","volume":"12","author":"Monk P.N.","year":"2012","unstructured":"Monk P.N.; Partridge L.J.; Tetraspanins: Gateways for infection. Infect Disord Drug Targets 2012,12(1),4-17","journal-title":"Infect Disord Drug Targets"},{"key":"ref=76","author":"Naudin C.","year":"2015","unstructured":"Naudin C.; Tetraspanin CD151\u2019s role in the kidney and mapping of genetic modifiers of glomerular disease. Thesis In: School of Biomedical Sciences and Pharmacy, University of Newcastle 2015","journal-title":"Thesis In: School of Biomedical Sciences and Pharmacy, University of Newcastle"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1172\/JCI61858","volume":"122","author":"Pozzi A.","year":"2012","unstructured":"Pozzi A.; Zent R.; Hold tight or you\u2019ll fall off: CD151 helps podocytes stick in high-pressure situations. J Clin Invest 2012,122(1),13-16","journal-title":"J Clin Invest"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1177\/002215549704500404","volume":"45","author":"Sincock P.M.","year":"1997","unstructured":"Sincock P.M.; Mayrhofer G.; Ashman L.K.; Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: Comparison with CD9, CD63, and alpha5beta1 integrin. J Histochem Cytochem 1997,45(4),515-525","journal-title":"J Histochem Cytochem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaci.2016.03.029","volume":"139","author":"Qiao Y.","year":"2017","unstructured":"Qiao Y.; Tam J.K.C.; Tan S.S.L.; CD151, a laminin receptor showing increased expression in asthmatic patients, contributes to airway hyperresponsiveness through calcium signaling. J Allergy Clin Immunol 2017,139(1),82-92.e5","journal-title":"J Allergy Clin Immunol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1164\/rccm.201201-0117OC","volume":"186","author":"Tsujino K.","year":"2012","unstructured":"Tsujino K.; Takeda Y.; Arai T.; Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity. Am J Respir Crit Care Med 2012,186(2),170-180","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3389\/fimmu.2018.01547","volume":"9","author":"Yip T.F.","year":"2018","unstructured":"Yip T.F.; Selim A.S.M.; Lian I.; Lee S.M.Y.; Advancements in host-based interventions for influenza treatment. Front Immunol 2018,9,1547","journal-title":"Front Immunol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.jaci.2017.11.032","volume":"141","author":"Qiao Y.","year":"2018","unstructured":"Qiao Y.; Yan Y.; Tan K.S.; CD151, a novel host factor of nuclear export signaling in influenza virus infection. J Allergy Clin Immunol 2018,141(5),1799-1817","journal-title":"J Allergy Clin Immunol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fcell.2020.00064","volume":"8","author":"Wong A.H.","year":"2020","unstructured":"Wong A.H.; Tran T.; CD151 in respiratory diseases. Front Cell Dev Biol 2020,8,64","journal-title":"Front Cell Dev Biol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/v6020893","volume":"6","author":"Scheffer K.","year":"2014","unstructured":"Scheffer K.; Berditchevski F.; Florin L.; The tetraspanin CD151 in papillomavirus infection. Viruses 2014,6(2),893-908","journal-title":"Viruses"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"e01429","DOI":"10.1128\/JVI.01429-17","volume":"93","author":"Hantak M.P.","year":"2019","unstructured":"Hantak M.P.; Qing E.; Earnest J.T.; Gallagher T.; Tetraspanins: Architects of viral entry and exit platforms. J Virol 2019,93(6),e01429-e17","journal-title":"J Virol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/JVI.02906-12","volume":"87","author":"Scheffer K.D.","year":"2013","unstructured":"Scheffer K.D.; Gawlitza A.; Spoden G.A.; Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J Virol 2013,87(6),3435-3446","journal-title":"J Virol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1128\/JVI.00145-16","volume":"90","author":"Hochdorfer D.","year":"2016","unstructured":"Hochdorfer D.; Florin L.; Sinzger C.; Lieber D.; Tetraspanin CD151 promotes initial events in human cytomegalovirus infection. J Virol 2016,90(14),6430-6442","journal-title":"J Virol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1128\/JVI.02539-05","volume":"80","author":"Ho S.H.","year":"2006","unstructured":"Ho S.H.; Martin F.; Higginbottom A.; Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1. J Virol 2006,80(13),6487-6496","journal-title":"J Virol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1042\/BST20160295","volume":"45","author":"Fast L.A.","year":"2017","unstructured":"Fast L.A.; Lieber D.; Lang T.; Florin L.; Tetraspanins in infections by human cytomegalo- and papillomaviruses. Biochem Soc Trans 2017,45(2),489-497","journal-title":"Biochem Soc Trans"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1472-6807-5-11","volume":"5","author":"Kovalenko O.V.","year":"2005","unstructured":"Kovalenko O.V.; Metcalf D.G.; DeGrado W.F.; Hemler M.E.; Structural organization and interactions of transmembrane domains in tetraspanin proteins. BMC Struct Biol 2005,5(1),11","journal-title":"BMC Struct Biol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1128\/JVI.00330-13","volume":"87","author":"Raff A.B.","year":"2013","unstructured":"Raff A.B.; Woodham A.W.; Raff L.M.; The evolving field of human papillomavirus receptor research: A review of binding and entry. J Virol 2013,87(11),6062-6072","journal-title":"J Virol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00430-012-0270-1","volume":"201","author":"Florin L.","year":"2012","unstructured":"Florin L.; Sapp M.; Spoden G.A.; Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol 2012,201(4),437-448","journal-title":"Med Microbiol Immunol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/v3030260","volume":"3","author":"Bienkowska-Haba M.","year":"2011","unstructured":"Bienkowska-Haba M.; Sapp M.; The cytoskeleton in papillomavirus infection. Viruses 2011,3(3),260-271","journal-title":"Viruses"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1242\/jcs.114.23.4143","volume":"114","author":"Berditchevski F.","year":"2001","unstructured":"Berditchevski F.; Complexes of tetraspanins with integrins: More than meets the eye. J Cell Sci 2001,114(23),4143-4151","journal-title":"J Cell Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1091\/mbc.01-05-0275","volume":"13","author":"Yang X.","year":"2002","unstructured":"Yang X.; Claas C.; Kraeft S.K.; Palmitoylation of tetraspanin proteins: Modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology. Mol Biol Cell 2002,13(3),767-781","journal-title":"Mol Biol Cell"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"e1002519","DOI":"10.1371\/journal.ppat.1002519","volume":"8","author":"Surviladze Z.","year":"2012","unstructured":"Surviladze Z.; Dziduszko A.; Ozbun M.A.; Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog 2012,8(2),e1002519","journal-title":"PLoS Pathog"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"e43519","DOI":"10.1371\/journal.pone.0043519","volume":"7","author":"Woodham A.W.","year":"2012","unstructured":"Woodham A.W.; Da Silva D.M.; Skeate J.G.; The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS One 2012,7(8),e43519","journal-title":"PLoS One"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1128\/JVI.00519-13","volume":"87","author":"Dziduszko A.","year":"2013","unstructured":"Dziduszko A.; Ozbun M.A.; Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes. J Virol 2013,87(13),7502-7515","journal-title":"J Virol"},{"key":"ref=99","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.01.446640","author":"Hysenaj L.","year":"2021","unstructured":"Hysenaj L.; Little S.; Kulhanek K.; SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator. BioRxiv 2021","journal-title":"BioRxiv"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"11609","DOI":"10.3390\/ijms222111609","volume":"22","author":"New C.","year":"2021","unstructured":"New C.; Lee Z.Y.; Tan K.S.; Wong A.H.P.; Wang D.Y.; Tran T.; Tetraspanins: Host factors in viral infections. Int J Mol Sci 2021,22(21),11609","journal-title":"Int J Mol Sci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbrc.2022.01.038","volume":"593","author":"Healy E.F.","year":"2022","unstructured":"Healy E.F.; How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17. Biochem Biophys Res Commun 2022,593,52-56","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/cells11040627","volume":"11","author":"Rouaud F.","year":"2022","unstructured":"Rouaud F.; M&#xE9;an I.; Citi S.; The ACE2 receptor for coronavirus entry is localized at apical cell\u2014cell junctions of epithelial cells. Cells 2022,11(4),627","journal-title":"Cells"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"2103471","DOI":"10.1002\/adma.202103471","volume":"33","author":"Xie F.","year":"2021","unstructured":"Xie F.; Su P.; Pan T.; Engineering extracellular vesicles enriched with palmitoylated ACE2 as COVID\u201019 therapy. Adv Mater 2021,33(49),2103471","journal-title":"Adv Mater"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"104422","DOI":"10.1016\/j.meegid.2020.104422","volume":"85","author":"Hassanpour M.","year":"2020","unstructured":"Hassanpour M.; Rezaie J.; Nouri M.; Panahi Y.; The role of extracellular vesicles in COVID-19 virus infection. Infect Genet Evol 2020,85,104422","journal-title":"Infect Genet Evol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"e1006546","DOI":"10.1371\/journal.ppat.1006546","volume":"13","author":"Earnest J.T.","year":"2017","unstructured":"Earnest J.T.; Hantak M.P.; Li K.; McCray P.B.; Perlman S.; Gallagher T.; The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases. PLoS Pathog 2017,13(7),e1006546","journal-title":"PLoS Pathog"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Ye Q.","year":"2020","unstructured":"Ye Q.; Wang B.; Mao J.; The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19. J Infect 2020,80(6),607-613","journal-title":"J Infect"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"Mehta P.","year":"2020","unstructured":"Mehta P.; McAuley D.F.; Brown M.; Sanchez E.; Tattersall R.S.; Manson J.J.; COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 2020,395(10229),1033-1034","journal-title":"Lancet"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3389\/fimmu.2018.01644","volume":"9","author":"Yeung L.","year":"2018","unstructured":"Yeung L.; Hickey M.J.; Wright M.D.; The many and varied roles of tetraspanins in immune cell recruitment and migration. Front Immunol 2018,9,1644","journal-title":"Front Immunol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ebiom.2019.10.025","volume":"49","author":"Lin W.","year":"2019","unstructured":"Lin W.; Liu J.; Chen J.; Peptides of tetraspanin oncoprotein CD151 trigger active immunity against primary tumour and experimental lung metastasis. EBioMedicine 2019,49,133-144","journal-title":"EBioMedicine"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/eji.201344235","volume":"44","author":"Rocha-Perugini V.","year":"2014","unstructured":"Rocha-Perugini V.; Gonz&#xE1;lez-Granado J.M.; Tejera E.; L&#xF3;pez-Mart&#xED;n S.; Ya&#xF1;ez-M&#xF3; M.; S&#xE1;nchez-Madrid F.; Tetraspanins CD9 and CD151 at the immune synapse support T-cell integrin signaling. Eur J Immunol 2014,44(7),1967-1975","journal-title":"Eur J Immunol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MIB.0000000000000621","volume":"22","author":"Zelman-Toister E.","year":"2016","unstructured":"Zelman-Toister E.; Bakos E.; Cohen S.; CD151 regulates T-cell migration in health and inflammatory bowel disease. Inflamm Bowel Dis 2016,22(2),257-267","journal-title":"Inflamm Bowel Dis"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/path.5415","volume":"251","author":"Hayward S.","year":"2020","unstructured":"Hayward S.; Gachehiladze M.; Badr N.; The CD151\u2010midkine pathway regulates the immune microenvironment in inflammatory breast cancer. J Pathol 2020,251(1),63-73","journal-title":"J Pathol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/imm.13329","volume":"163","author":"Xia X.","year":"2021","unstructured":"Xia X.; Yuan P.; Liu Y.; Wang Y.; Cao W.; Zheng J.C.; Emerging roles of extracellular vesicles in COVID\u201019, a double\u2010edged sword? Immunology 2021,163(4),416-430","journal-title":"Immunology"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.procbio.2017.12.004","volume":"66","author":"Gavara M.M.","year":"2018","unstructured":"Gavara M.M.; Zaveri K.; Badana A.K.; A novel small molecule inhibitor of CD151 inhibits proliferation of metastatic triple negative breast cancer cell lines. Process Biochem 2018,66,254-262","journal-title":"Process Biochem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12977-016-0247-z","volume":"13","author":"Zhang Q.","year":"2016","unstructured":"Zhang Q.; Mi Z.; Huang Y.; 2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation. Retrovirology 2016,13(1),13","journal-title":"Retrovirology"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s00018-019-03014-7","volume":"76","author":"Hwang S.","year":"2019","unstructured":"Hwang S.; Takimoto T.; Hemler M.E.; Integrin-independent support of cancer drug resistance by tetraspanin CD151. Cell Mol Life Sci 2019,76(8),1595-1604","journal-title":"Cell Mol Life Sci"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0893-133X(01)00269-X","volume":"25","author":"Hua L.","year":"2001","unstructured":"Hua L.; Green M.; Wong A.; Warsh J.J.; Li P.P.; Tetraspan protein CD151: A common target of mood stabilizing drugs? Neuropsychopharmacology 2001,25(5),729-736","journal-title":"Neuropsychopharmacology"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1042\/BST0390553","volume":"39","author":"Haeuw J.F.","year":"2011","unstructured":"Haeuw J.F.; Goetsch L.; Bailly C.; Corvaia N.; Tetraspanin CD151 as a target for antibody-based cancer immunotherapy. Biochem Soc Trans 2011,39(2),553-558","journal-title":"Biochem Soc Trans"},{"key":"ref=119","first-page":"3812","volume":"59","author":"Testa J.E.","year":"1999","unstructured":"Testa J.E.; Brooks P.C.; Lin J.M.; Quigley J.P.; Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3\/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res 1999,59(15),3812-3820","journal-title":"Cancer Res"},{"key":"ref=120","first-page":"104","volume":"8","author":"Devi G.V.","year":"2016","unstructured":"Devi G.V.; Badana A.; Kumari S.; Nagaseshu P.; Malla R.; Therapeutic potentials of CD151 shRNA in targeting metastasis of triple negative breast cancer cell line MDA-MB-231. J Cancer Sci Ther 2016,8,104-112","journal-title":"J Cancer Sci Ther"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11010-015-2459-2","volume":"407","author":"Liu T.","year":"2015","unstructured":"Liu T.; wang S, Wang L, Wang J, Li Y. Targeting CD151 by lentivirus-mediated RNA interference inhibits luminal and basal-like breast cancer cell growth and invasion. Mol Cell Biochem 2015,407(1-2),111-121","journal-title":"Mol Cell Biochem"},{"key":"ref=122","first-page":"2","volume":"4","author":"Devi G.","year":"2017","unstructured":"Devi G.; Badana A.; Madhuri Ch M.M.P.; Naik S.; Knockdown of CD151 gene expression reduces survival of estrogen receptor positive breast cancer cells. J Clin Exp Oncol 2017,4,2","journal-title":"J Clin Exp Oncol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1159\/000350100","volume":"31","author":"Han Z.B.","year":"2013","unstructured":"Han Z.B.; Yang Z.; Chi Y.; microRNA-124 suppresses breast cancer cell growth and motility by targeting CD151. Cell Physiol Biochem 2013,31(6),823-832","journal-title":"Cell Physiol Biochem"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"108872","DOI":"10.1016\/j.cbi.2019.108872","volume":"315","author":"Kgk D.","year":"2020","unstructured":"Kgk D.; Kumari S.; Shailender G.; Malla R.R.; Marine natural compound cyclo(L-leucyl-L-prolyl) peptide inhibits migration of triple negative breast cancer cells by disrupting interaction of CD151 and EGFR signaling. Chem Biol Interact 2020,315,108872","journal-title":"Chem Biol Interact"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"100551","DOI":"10.1016\/j.genrep.2019.100551","volume":"17","author":"Akella M.","year":"2019","unstructured":"Akella M.; Amajala K.C.; Malla R.R.; Bioinformatics analysis of regulatory elements of the CD151 gene and insilico docking of CD151 with diallyl sulfide. Gene Rep 2019,17,100551","journal-title":"Gene Rep"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00535-009-0081-3","volume":"44","author":"Nakamoto T.","year":"2009","unstructured":"Nakamoto T.; Murayama Y.; Oritani K.; A novel therapeutic strategy with anti-CD9 antibody in gastric cancers. J Gastroenterol 2009,44(9),889-896","journal-title":"J Gastroenterol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"e0160387","DOI":"10.1371\/journal.pone.0160387","volume":"11","author":"Ventress J.K.","year":"2016","unstructured":"Ventress J.K.; Partridge L.J.; Read R.C.; Cozens D.; MacNeil S.; Monk P.N.; Peptides from tetraspanin CD9 are potent inhibitors of Staphylococcus aureus adherence to keratinocytes. PLoS One 2016,11(7),e0160387","journal-title":"PLoS One"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1039\/D1CC01295A","volume":"57","author":"Suwatthanarak T.","year":"2021","unstructured":"Suwatthanarak T.; Tanaka M.; Miyamoto Y.; Miyado K.; Okochi M.; Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide. Chem Commun 2021,57(40),4906-4909","journal-title":"Chem Commun"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220907105543","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208591\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220907105543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T04:19:47Z","timestamp":1691727587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208591\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":128,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612828666220907105543","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}